Search Results
Results found for "Jaume Lillo"
Posts (15)
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
angiotensin II-induced calcium signaling in striatal neurons Rafael Rivas-Santisteban , Ana Muñoz , Jaume Lillo , Iu Raïch , Ana Rodríguez-Pérez , Gemma Navarro , José Labandeira-García , Rafael Franco Endomembrane
- How System-Level GPCR Thinking Prevents Discovery Failures
Breakthroughs this week: Eli Lilly cuts Zepbound prices; GNAI1 missense mutation study; rapid Gαs endosomal translocation. 🔍 This Week in Premium: Sneak Peek Industry insights: Lilly cuts Zepbound prices; Lilly
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Breakthroughs this week: Decoding ADGRE5 signaling; Eli Lilly’s obesity pill vs Novo’s Wegovy; Certa Metabolic GPCRs in the spotlight; receptor motion tracking tools; obesity treatment race between Eli Lilly
Other Pages (4)
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
After 7 years at WL/PD and 26 years at Eli Lilly & Co., he retired at the end of 2014 and since then has been writing papers on his final major project at Lilly, a dopamine D1 PAM series that has advanced In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
of new drugs targeting specific receptors for various diseases, with Arthur sharing insights on Eli Lilly's
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
of new drugs targeting specific receptors for various diseases, with Arthur sharing insights on Eli Lilly's
